Blue Buffalo Pet Products Inc. (NASDAQ:BUFF) released its quarterly earnings data on Thursday. The company reported $0.22 EPS for the quarter, beating the consensus estimate of $0.20 by $0.02. The company earned $288 million during the quarter, compared to the consensus estimate of $290.29 million. Blue Buffalo Pet Products had a return on equity of 406.20% and a net margin of 10.14%. The firm’s revenue for the quarter was up 11.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.14 EPS. Blue Buffalo Pet Products updated its FY16 guidance to $0.78-0.79 EPS.

Blue Buffalo Pet Products (NASDAQ:BUFF) opened at 23.86 on Friday. The firm’s 50-day moving average price is $24.55 and its 200 day moving average price is $25.13. The company has a market cap of $4687.18 billion, a PE ratio of 43.38 and a beta of 2.27. Blue Buffalo Pet Products has a 52-week low of $15.19 and a 52-week high of $27.50.

Earnings History for Blue Buffalo Pet Products (NASDAQ:BUFF)

Several equities research analysts have recently commented on BUFF shares. DA Davidson started coverage on Blue Buffalo Pet Products in a report on Wednesday, October 5th. They issued a “buy” rating and a $29.00 price objective for the company. Zacks Investment Research raised Blue Buffalo Pet Products from a “hold” rating to a “buy” rating and set a $26.00 price objective for the company in a report on Tuesday, September 27th. Deutsche Bank AG increased their price objective on Blue Buffalo Pet Products from $28.00 to $30.00 and gave the company a “buy” rating in a report on Thursday, August 11th. Citigroup Inc. increased their price objective on Blue Buffalo Pet Products from $30.00 to $31.00 and gave the company a “buy” rating in a report on Thursday, August 11th. Finally, Susquehanna restated a “buy” rating and issued a $29.00 price target on shares of Blue Buffalo Pet Products in a research note on Tuesday. Two analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $29.50.

In related news, Director L.P. Invus sold 12,512,124 shares of Blue Buffalo Pet Products stock in a transaction that occurred on Friday, September 16th. The stock was sold at an average price of $24.83, for a total transaction of $310,676,038.92. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Kurt Schmidt sold 50,000 shares of Blue Buffalo Pet Products stock in a transaction that occurred on Friday, September 16th. The shares were sold at an average price of $24.83, for a total value of $1,241,500.00. Following the transaction, the chief executive officer now directly owns 103,571 shares in the company, valued at approximately $2,571,667.93. The disclosure for this sale can be found here. Insiders own 10.30% of the company’s stock.

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. boosted its position in shares of Blue Buffalo Pet Products by 94.0% in the second quarter. Vanguard Group Inc. now owns 5,299,211 shares of the company’s stock valued at $123,683,000 after buying an additional 2,567,667 shares during the last quarter. Bank of New York Mellon Corp boosted its position in shares of Blue Buffalo Pet Products by 1,664.1% in the second quarter. Bank of New York Mellon Corp now owns 1,886,140 shares of the company’s stock valued at $44,021,000 after buying an additional 1,779,224 shares during the last quarter. American Century Companies Inc. bought a new position in shares of Blue Buffalo Pet Products during the second quarter valued at about $38,618,000. BlackRock Institutional Trust Company N.A. boosted its position in shares of Blue Buffalo Pet Products by 68.0% in the third quarter. BlackRock Institutional Trust Company N.A. now owns 2,439,087 shares of the company’s stock valued at $57,953,000 after buying an additional 987,288 shares during the last quarter. Finally, Morgan Stanley boosted its position in shares of Blue Buffalo Pet Products by 206.4% in the third quarter. Morgan Stanley now owns 1,055,520 shares of the company’s stock valued at $25,079,000 after buying an additional 711,000 shares during the last quarter. 90.39% of the stock is currently owned by institutional investors.

About Blue Buffalo Pet Products

Blue Buffalo Pet Products, Inc (BBPP) is a holding company. The Company, through its subsidiaries, develops, produces, markets and sells pet food under the BLUE Life Protection Formula, BLUE Wilderness, BLUE Basics, BLUE Freedom and BLUE Natural Veterinary Diet lines. Blue Buffalo Company, Ltd. (Blue), Blue Buffalo Import Mexico, S.

5 Day Chart for NASDAQ:BUFF

Receive News & Stock Ratings for Blue Buffalo Pet Products Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blue Buffalo Pet Products Inc. and related stocks with our FREE daily email newsletter.